|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4152 | |
| A61P 25/28 | |||
| C07D 231/26 |
| (11) | Number of the document | 2754440 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12830484.7 |
| Date of filing the European patent application | 2012-09-05 | |
| (97) | Date of publication of the European application | 2014-07-16 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2012/072544 |
| Date | 2012-09-05 |
| (87) | Number | WO 2013/035712 |
| Date | 2013-03-14 |
| (30) | Number | Date | Country code |
| 2011192288 | 2011-09-05 | JP |
| (72) |
YONEOKA, Takatomo, JP
|
| (73) |
Mitsubishi Tanabe Pharma Corporation,
3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505,
JP
|
| (54) | MEDICINAL AGENT FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS OR PREVENTING PROGRESSION OF PHASE OF AMYOTROPHIC LATERAL SCLEROSIS |
| MEDICINAL AGENT FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS OR PREVENTING PROGRESSION OF PHASE OF AMYOTROPHIC LATERAL SCLEROSIS |